Simplex Trading’s TherapeuticsMD TXMD Stock Holding History

Simplex Trading’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.3K	Buy	13,000 +300	+2%	+$675	﹤0.01%	6531
2025 Q4	$20.7K	Buy	+12,700	New	+$18.4K	﹤0.01%	6444
2023 Q4	–	Sell	-19,000	Closed	-$57K	–	9865
2023 Q3	$57K	Buy	19,000 +100	+0.5%	+$378	﹤0.01%	5688
2023 Q2	$77K	Sell	18,900 -2,300	-11%	-$9.02K	﹤0.01%	5378
2023 Q1	$79K	Sell	21,200 -59,100	-74%	-$284K	﹤0.01%	5436
2022 Q4	$448K	Sell	80,300 -3,700	-4%	-$21.8K	﹤0.01%	3269
2022 Q3	$557K	Sell	84,000 -14,100	-14%	-$114K	﹤0.01%	3350
2022 Q2	$976K	Buy	98,100 +96,208	+5,085%	+$919K	﹤0.01%	2653
2022 Q1	$35K	Sell	1,892 -2,490	-57%	-$39.2K	﹤0.01%	7614
2021 Q4	$77K	Sell	4,382 -606	-12%	-$18.2K	﹤0.01%	6642
2021 Q3	$301K	Buy	4,988 +378	+8%	+$16.8K	﹤0.01%	4906
2021 Q2	$274K	Buy	+4,610	New	+$279K	﹤0.01%	5146
2021 Q1	–	Sell	-35	Closed	-$213K	–	10071
2020 Q4	$213K	Buy	35 +11	+46%	+$751	﹤0.01%	4516
2020 Q3	$192K	Buy	24 +13	+118%	+$1.04K	﹤0.01%	4170
2020 Q2	$71K	Sell	11 -20	-65%	-$1.16K	﹤0.01%	5162
2020 Q1	$164K	Buy	31 +25	+417%	+$2.48K	﹤0.01%	3820
2019 Q4	$67K	Buy	6 +2	+50%	+$288	﹤0.01%	4924
2019 Q3	$70K	Sell	4 -7	-64%	-$987	﹤0.01%	4699
2019 Q2	$146K	Buy	11 +10	+1,000%	+$1.79K	﹤0.01%	3801
2019 Q1	$23K	Sell	1 -16	-94%	-$4.23K	﹤0.01%	5627
2018 Q4	$319K	Buy	17 +2	+13%	+$488	﹤0.01%	2656
2018 Q3	$485K	Buy	15 +10	+200%	+$3.06K	﹤0.01%	2659
2018 Q2	$159K	Buy	5 +2	+67%	+$611	﹤0.01%	3755
2018 Q1	$12K	Sell	3 -10	-77%	-$2.81K	﹤0.01%	3890
2017 Q4	$59K	Buy	+13	New	+$3.62K	﹤0.01%	2283
2017 Q3	–	Sell	-2	Closed	-$578	–	5587
2017 Q2	$6K	Sell	2 -2	-50%	-$501	﹤0.01%	4471
2017 Q1	$4K	Sell	4 -13	-76%	-$4.02K	﹤0.01%	4824
2016 Q4	$17K	Buy	17 +8	+89%	+$2.48K	﹤0.01%	3197
2016 Q3	$18K	Buy	9 +4	+80%	+$1.46K	﹤0.01%	3088
2016 Q2	$36K	Sell	5 -15	-75%	-$6.18K	﹤0.01%	2371
2016 Q1	$24K	Buy	20 +10	+100%	+$3.41K	﹤0.01%	2643
2015 Q4	$89K	Buy	10 +1	+11%	+$369	0.01%	1453
2015 Q3	$23K	Buy	9 +3	+50%	+$1.07K	﹤0.01%	2660
2015 Q2	$30K	Buy	6 +5	+500%	+$1.76K	﹤0.01%	2101
2015 Q1	$7K	Hold	1	–	–	﹤0.01%	3254
2014 Q4	$3K	Buy	+1	New	+$206	﹤0.01%	3533

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TXMD Position: Q3 2025 in Review

Simplex Trading sold out of TherapeuticsMD (TXMD) in Q3 2025, closing a stake of 428 shares — an estimated $480 sold.

Simplex Trading first reported a position in TXMD in Q2 2015 and held it in 18 quarters. The position peaked at $273K in Q3 2018. 46 funds tracked by Wall St. Rank hold TXMD as of Q3 2025.

Simplex Trading reported no remaining TherapeuticsMD position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 428 TherapeuticsMD shares in Q3 2025, an estimated $480.
Simplex Trading first reported a position in TherapeuticsMD in Q2 2015 and held it in 18 quarters.
Simplex Trading's TherapeuticsMD position peaked at $273K in Q3 2018.
46 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.